Lv1
90 积分 2025-02-17 加入
LBA38 Iparomlimab and tuvonralimab (QL1706) with bevacizumab and/or chemotherapy in first-line (1L) treatment of advanced hepatocellular carcinoma (aHCC): A randomized, open-label, phase II/III study (DUBHE-H-308)
3天前
已完结
Safety and Efficacy of Iruplinalkib for Patients with Relapsed or Refractory (r/r) ALK+ Lymphoma: A Phase II Trial
1个月前
已关闭
伊鲁阿克治疗间变性淋巴瘤激酶融合基因阳性局部晚期或转移性非小细胞肺癌中国专家共识（2024版）
2个月前
已完结
肺癌常用标志物检测及临床应用专家共识（2026版）
2个月前
已完结
皖公网安备34019202002308
